It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Cornified skin appendages, such as hair and nails, are major evolutionary innovations of terrestrial vertebrates. Human hair and nails consist largely of special intermediate filament proteins, known as hair keratins, which are expressed under the control of the transcription factor Hoxc13. Here, we show that the cornified claws of Xenopus frogs contain homologs of hair keratins and the genes encoding these keratins are flanked by promoters in which binding sites of Hoxc13 are conserved. Furthermore, these keratins and Hoxc13 are co-expressed in the claw-forming epithelium of frog toe tips. Upon deletion of hoxc13, the expression of hair keratin homologs is abolished and the development of cornified claws is abrogated in X. tropicalis. These results indicate that Hoxc13-dependent expression of hair keratin homologs evolved already in stem tetrapods, presumably as a mechanism for protecting toe tips, and that this ancestral genetic program was coopted to the growth of hair in mammals.
Hair is the main skin appendage of mammals. Here, the authors show that claws of clawed frogs and hair contain homologous keratins and depend on the same transcription factor, Hoxc13, suggesting a common evolutionary origin of these skin appendages.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Sachslehner, Attila Placido 2
; Cicekdal, Munevver Burcu 1
; Bruggeman, Inge 3 ; Demuynck, Suzan 4 ; Golabi, Bahar 2 ; De Baere, Elfride 5
; Declercq, Wim 3
; Tschachler, Erwin 2 ; Vleminckx, Kris 4
; Eckhart, Leopold 2
1 Ghent University, Department of Biomedical Molecular Biology, Ghent, Belgium (GRID:grid.5342.0) (ISNI:0000 0001 2069 7798); Ghent University Hospital, Department of Biomolecular Medicine, Ghent University and Center for Medical Genetics, Ghent, Belgium (GRID:grid.410566.0) (ISNI:0000 0004 0626 3303)
2 Medical University of Vienna, Department of Dermatology, Vienna, Austria (GRID:grid.22937.3d) (ISNI:0000 0000 9259 8492)
3 Ghent University, Department of Biomedical Molecular Biology, Ghent, Belgium (GRID:grid.5342.0) (ISNI:0000 0001 2069 7798); VIB-Ugent Center for Inflammation Research, Ghent, Belgium (GRID:grid.510970.a)
4 Ghent University, Department of Biomedical Molecular Biology, Ghent, Belgium (GRID:grid.5342.0) (ISNI:0000 0001 2069 7798)
5 Ghent University Hospital, Department of Biomolecular Medicine, Ghent University and Center for Medical Genetics, Ghent, Belgium (GRID:grid.410566.0) (ISNI:0000 0004 0626 3303)




